Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

Diabetic kidney disease (DKD) is a severe complication of type 2 diabetes mellitus (T2DM). However, the pathogenesis of DKD remains unclear, and effective treatment strategies are still lacking. Ginsenoside Rg1 (Rg1) has been reported to improve DKD, but the mechanism is unclear. NADPH oxidase 4 (NO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Pengmin, Shi, Qifeng, Liu, Yan, Han, Min, Su, Yong, Sun, Ran, Zhou, Huimin, Li, Weizu, Li, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078147/
https://www.ncbi.nlm.nih.gov/pubmed/37017270
http://dx.doi.org/10.1080/0886022X.2023.2197075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078147/
https://www.ncbi.nlm.nih.gov/pubmed/37017270
http://dx.doi.org/10.1080/0886022X.2023.2197075

Ejemplares similares